Table 2.
Biomarkers by 28-day survival status of melioidosis patients.
| Biomarker (pg/ml): median (IQR) | All (N = 78) | Survivors (N = 49) | Non-survivors (N = 29) | P value |
|---|---|---|---|---|
| IL-1R2 | 116,823 (52,553-238,368) | 59,429 (38,175-147,727) | 199,846 (128,661-274,000) | <0.001 |
| CRP | 631,247 (491,097-722,272) | 629,802 (482,428-690,485) | 638,471 (508,435-730,941) | 0.45 |
| PCT | 1841 (913–2025) | 1,677 (697–1983) | 1966 (1824–2037) | 0.004 |
| sTREM-1 | 200 (137–440) | 187 (112–301) | 238 (187–491) | 0.05 |
| S100A9 | 3,206 (2575–4,044) | 3,023 (2327–3,720) | 3,673 (2652–4,230) | 0.10 |
| Calprotectin | 1.5×107 (9.2 ×106-2.3×107) | 1.2×107 (8.2×106-2.4×107) | 1.7×107 (1×107-2.2×107) | 0.22 |